Sumatriptan relieves migrainelike headaches associated with carbon monoxide exposure

Headache

Volumn 37, Issue 6, 1997, Pages 392-395

  Lipton, Richard B ^a,b,c   Mazer, Cynthia ^a   Newman, Lawrence C ^a   Solomon, Seymour ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Montefiore Med Ctr Innov Med R   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Carbon monoxide; Migraine; Sumatriptan

Indexed keywords

SUMATRIPTAN;

ADULT; ARTICLE; CARBON MONOXIDE INTOXICATION; CASE REPORT; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; FURNACE; HEADACHE; HUMAN; INDOOR AIR POLLUTION; MIGRAINE; PRIORITY JOURNAL;

CARBON MONOXIDE POISONING; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MIDDLE AGED; MIGRAINE DISORDERS; SEROTONIN AGONISTS; SUMATRIPTAN;

EID: 0030857151     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.1997.3706392.x     Document Type: Article

References (39)

1. Moskowitz MA, Cutrer FM. Sumatriptan: a receptor-targeted treatment for migraine. Annu Rev Med. 1993;44:145-154.
2. Moskowitz MA. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci. 1992;13:307-311.
3. Moskowitz MA. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology. 1993;43(suppl 3):S16-S20.
4. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl 7):1-96.
5. Silvers SM, Hampson NB. Carbon monoxide poisoning among recreational boaters. JAMA. 1995;274:1614-1616.
6. Fawcett TA, Moon RE, Fracica PJ, Mebane GY, Theil DR, Piantadosi CA. Warehouse workers' headache. Carbon monoxide poisoning from propane-fueled forklifts. J Occup Med. 1992;34:12-15.
7. From the Centers for Disease Control and Prevention. Un-intentional carbon monoxide poisonings in residential settings - Connecticut, November 1993-March 1994. JAMA. 1995;274:1579-1581.
8. Tomaszewski C. Carbon monoxide. In: Goldfrank LR, Flomenbaum NE, Lewin NA, et al, eds. Goldfrank's Toxicologic Emergencies. Norwalk, Conn: Appleton & Lange; 1994;1199-1210.
9. Pereira Monteiro JM. Headache associated with single use of substances. In: Olesen J, Tfelt-Hansen P, Welch KMA, eds. The Headaches. New York: Raven Press; 1993;715-717.
10. Ginsberg MD. Carbon monoxide intoxication: clinical features, neuropathology and mechanisms of injury. J Toxicol Clin Toxicol. 1985;23:281-288.
11. Chisholm CD, Reilly J, Berejan B. Carboxyhemoglobin levels in patients with headache. Ann Emerg Med. 1987. Abstract.
12. Dolan MC, Haltom TL, Barrows GH, Short CS, Ferried KM. Carboxyhemoglobin levels in patients with flu-like symptoms. Ann Emerg Med. 1987;16:782-786.
13. Greene C, Lumpkin JR, Baker FJ II. Association between unsuspected carbon monoxide exposure and headache. Ann Emerg Med. 1983;244.
14. Heckerling PS, Leikin JB, Maturen A, Perkins JT. Predictors of occult carbon monoxide poisoning in patients with headache and dizziness. Ann Intern Med. 1987;107:174-176.
15. Hutter GM. Warehouse workers' headache. J Occup Med. 1992;34:870-872.
16. Fleming JL, Opheim GS. Warehouse workers' headache. J Occup Med. 1992;34:872.
17. Mikkelsen S, Henry P. Occupation and headache. In: Olesen J, Tfelt-Hansen P, Welch KMA, eds. The Headaches. New York: Raven Press; 1993:821-822.
18. Nathanson JA, Scavone C, Scanlon C, McKee M. The cellular Na+ pump as a site of action for carbon monoxide and glutamate: a mechanism for long-term modulation of cellular activity. Neuron. 1995;14:781-794.
19. Dawson TM, Snyder SH. Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J Neurosci. 1994;14:5147-5159.
20. Furchgott RF, Jothianandan D. Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels. 1991;28:52-61.
21. Olesen J, Iversen HK, Thomsen LL. Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain. Neuroreport. 1993;4:1027-1030.
22. Thomsen LL, Iversen HK, Olesen J. Cerebral blood flow velocities are reduced during attacks of unilateral migraine without aura. Cephalalgia. 1995;15:109-116.
23. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.
24. Edvinsson L, Jansen I. Vasomotor responses and receptor characteristics of human cranial arteries and veins. In: Olesen J, Tfelt-Hansen P, Welch KMA, eds. The Headaches. New York: Raven Press; 1993:117-127.
25. Sicuteri F, Del Bene E, Poggioni M, Bonazzi A. Unmasking latent dysnociception in healthy subjects. Headache. 1987;27:180-185.
26. Iversen HK, Nielsen TH, Garre K, Tfelt-Hansen P, Olesen J. Dose-dependent headache response and dilatation of limb and extracranial arteries after three doses of 5-isosorbide-mononitrate. Eur J Clin Pharmacol. 1992;42:31-35.
27. Olesen J, Thomsen LL, Lassen LH, Olesen IJ. The nitric oxide hypothesis of migraine and other vascular headaches. Cephalalgia. 1995;15:94-100.
28. Iversen HK, Olesen J, Tfelt-Hansen P. Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics. Pain. 1989;38:17-24.
29. Park KH, Rubin LE, Gross SS, Levi R. Nitric oxide is a mediator of hypoxic coronary vasodilatation. Relation to adenosine and cyclooxygenase-derived metabolites. Circ Res. 1992;71:992-1001.
30. Horwitz LD, Herman MV, Gorlin R. Clinical response to nitroglycerin as a diagnostic test for coronary artery disease. Am J Cardiol. 1972;29:149-153.
31. Thomsen LL, Kruuse C, Iversen HK, Olesen J. A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks. Eur J Neurol. 1994;1:73-80.
32. Thomsen LL, Iversen HK, Brinck TA, Diesen J. Arterial supersensitivity to nitric oxide (nitroglycerin) in migraine sufferers. Cephalalgia. 1993;13:395-399.
33. Moskowitz MA, Macfarlane R. Neurovascular and molecular mechanisms in migraine headaches. Cerebrovasc Brain Metab Rev. 1993;5:159-177.
34. Buzzi MG, Moskowitz MA. The trigemino-vascular system and migraine. Path Biol. 1992;40:313-317.
35. Knappertz VA, Tegeler CH, Davidai G, Mitchell ES. Nitroglycerin-induced headache responds to sumatriptan. Neurology. 1996;46:A204. Abstract.
36. Moskowitz MA, Buzzi MG. Neuroeffector functions of sensory fibres: implications for headache mechanisms and drug actions. J Neurol. 1991;238(suppl 1):S18-S22.
37. Olesen J, Thomsen LL, Iversen H. Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol Sci. 1994;15:149-153.
38. Olesen J, Edvinsson L. Migraine: a research field matured for the basic neurosciences. Trends Neurosci. 1991;14:3-5.
39. Tfelt-Hansen P. Sumatriptan for the treatment of migraine attacks - a review of controlled clinical trials. Cephalalgia. 1993;13:238-244.